
Thursday Jul 03, 2025
On patient-centric treatment decisions and the value of quantitative methodologies, in conversation with Marc Buyse
In today's healthcare landscape, there is a pressing need for quantitative methodologies that include the patients' perspective in any treatment decision.
In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, about his recent work as one of the editors of โ and a chapter contributor to โ the first edition of "๐๐ข๐ฏ๐ฅ๐ฃ๐ฐ๐ฐ๐ฌ ๐ฐ๐ง ๐๐ฆ๐ฏ๐ฆ๐ณ๐ข๐ญ๐ช๐ป๐ฆ๐ฅ ๐๐ข๐ช๐ณ๐ธ๐ช๐ด๐ฆ ๐๐ฐ๐ฎ๐ฑ๐ข๐ณ๐ช๐ด๐ฐ๐ฏ๐ด: ๐๐ฆ๐ต๐ฉ๐ฐ๐ฅ๐ด ๐ง๐ฐ๐ณ ๐๐ข๐ต๐ช๐ฆ๐ฏ๐ต-๐๐ฆ๐ฏ๐ต๐ณ๐ช๐ค ๐๐ฏ๐ข๐ญ๐บ๐ด๐ช๐ด", recently published by the Routledge Taylor & Francis Group.
The conversation explores generalised pairwise comparisons (or GPCs), applications in various disease areas, implications for regulatory approvals and benefit-risk analyses, and considerations for patient-centricity in clinical research and treatment decisions.
You can also listen to episode 189a of theโฏpharmaphorum podcastโฏin the player below, download the episode to your computer, or find it - and subscribe to the rest of the series โ onย Apple Podcasts,ย Spotify, Overcast, Pocket Casts,ย Podbean, and pretty much wherever else you download your other podcasts from.
No comments yet. Be the first to say something!